Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Inclusion Criteria: * Healthy males or healthy non-pregnant females 18 to 65 years of age at the time of informed consent who are willing to either practice abstinence or 2 barrier methods of birth control or 1 barrier method and an oral contraceptive method * Participants must be in good general health (not suffering from a serious chronic mental or physical disorder that has required or may in the near future require urgent medical care) * Body mass index between 19 to 32 kg/m\^2 * Ability to eat the high-fat meal Exclusion Criteria: * Participants with a history of skin sensitivity to adhesive medical tape or metals * Participants who, in the opinion of the investigator, is acutely psychotic or manic and has symptoms currently requiring hospitalization * Participants with a history or evidence of a medical condition that would expose him or her to an undue risk of a significant adverse event (AE) or interfere with assessments of safety during the course of the trial * Participants have received any investigational product within the last 30 days. * Participants has a current history of drug or alcohol dependence that meets Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria * Participants has the presence of cognitive impairment * Participants currently taking antipsychotic medication * Participants with a terminal illness * Participants with a history of chronic dermatitis * Participants with a history of gastrointestinal surgery that could impair absorption * Female participants who are breastfeeding and/or who have a positive serum pregnancy test result prior to receiving trial medications * Sexually active women of childbearing potential (WOCBP) who will not commit to using 2 forms of approved birth control methods or who will not remain abstinent during this trial and for 30 days following the last dose of trial medication * Sexually active males who will not commit to using 2 of the approved birth control methods or who will not remain abstinent for the duration of the trial and for 90 days following the last dose of trial medication * No permanent physical residence * After resting for ≥3 minutes, have a sitting systolic blood pressure \<100 or ≥150 millimeters of mercury (mmHg) and/or diastolic blood pressure \<50 or ≥90 mmHg * After resting for ≥3 minutes, have a sitting pulse rate \<35 or \>100 beats per minute * Participants who, in the opinion of the investigator, should not participate in the trial